Press Release: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 April 2014

The Pharmacovigilance Risk Assessment Committee (PRAC) gave a recommendation on one safety review and started four new safety reviews at its April meeting.

• Primary Source

ESO: Background information: Press Release: PRAC recommends against combined use of medicines affecting the renin-angiotensin (RAS) system http://www.europeansources.info/record/press-release-prac-recommends-against-combined-use-of-medicines-affecting-the-renin-angiotensin-ras-system/

ESO: Background information: Press Release: Start of review of ambroxol and bromhexine http://www.europeansources.info/record/press-release-start-of-review-of-ambroxol-and-bromhexine/

ESO: Background information: Press Release: Start of review of codeine-containing medicines when used for cough and cold in children http://www.europeansources.info/record/press-release-start-of-review-of-codeine-containing-medicines-when-used-for-cough-and-cold-in-children/

ESO: Background information: Press Release: Review of oral methadone medicines containing povidone started http://www.europeansources.info/record/press-release-review-of-oral-methadone-medicines-containing-povidone-started/

ESO: Background information: Press Release: Review of testosterone-containing medicines started http://www.europeansources.info/record/press-release-review-of-testosterone-containing-medicines-started/

ESO: Background information: Press Release: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3-6 March 2014 http://www.europeansources.info/record/press-release-meeting-highlights-from-the-pharmacovigilance-risk-assessment-committee-prac-3-6-march-2014/

---